Vol 8, No 3 (June 29, 2019): Chinese Clinical Oncology (Challenges and Insights of Early Oncology Drug Development in the Asia-Pacific Region)

Preface on Challenges and Insights of Early Oncology Drug Development in the Asia- Pacific Region¹

Trends in phase 1 oncology drug development in East-Asia and Australia

Brigette B. Y. Ma

PDF Pages: 22 Full Text (2287) Open Access

Review Article on Challenges and Insights of Early Oncology Drug Development in the Asia-Pacific Region¹

The value of networks in driving phase I trials: the Peter MacCallum Cancer Centre experience

Jayesh Desai, Christina Guo, Ben Tran

PDF Pages: 23 Full Text (2518) Open Access

Population diversity in oncology drug responses and implications to drug development

Robert Walsh, Boon-Cher Goh

PDF Pages: 24 Full Text (3327) Open Access

Challenges of the phase I drug development in non-small cell lung cancer

Chia-Chi Lin

PDF Pages: 25 Full Text (2451) Open Access

Challenges and insights of early phase oncology drug development in the Asia-Pacific region

Herbert H. Loong, Daniel S. W. Tan, Toshio Shimizu

PDF Pages: 26 Full Text (3577) Open Access

Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea

Seock-Ah Im, Dae-Won Lee, Ryungwoo Kang, Jee Hyun Kim, Dong-Wan Kim, In-Jin Jang, Jong-Seok Lee, Yung-Jue Bang

PDF Pages: 27 Full Text (4104) Open Access

Original Article

Thymidylate synthase gene polymorphism predicts disease free survival in stage II–III rectal adenocarcinoma patients receiving adjuvant 5-FU-based chemotherapy

Xiaona Su, Songlin Li, Hui Zhang, He Xiao, Chuan Chen, Ge Wang

PDF Pages: 28 Full Text (1577) Open Access

Case Report

Osimertinib in the treatment of leptomeningeal disease in T790M-negative, epidermal growth factor receptor-mutated non-small cell lung cancer: a case report

Julia Chen, Hussein Soudy

PDF Pages: 29 Full Text (2968) Open Access

Disclosure:

1. The series “Challenges and Insights of Early Oncology Drug Development in the Asia- Pacific Region” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Brigette B. Y. Ma served as the unpaid Guest Editor for the series.